Hls Therapeutics Stock Price History
| HLS Stock | CAD 4.99 0.09 1.84% |
Below is the normalized historical share price chart for HLS Therapeutics extending back to March 28, 1980. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of HLS Therapeutics stands at 4.99, as last reported on the 22nd of July, with the highest price reaching 5.00 and the lowest price hitting 4.86 during the day.
If you're considering investing in HLS Stock, it is important to understand the factors that can impact its price. HLS Therapeutics appears to be slightly risky, given 3 months investment horizon. HLS Therapeutics holds Efficiency (Sharpe) Ratio of 0.16, which attests that the entity had a 0.16 % return per unit of volatility over the last 3 months. We have found twenty-eight technical indicators for HLS Therapeutics, which you can use to evaluate the volatility of the firm. Please utilize HLS Therapeutics' risk adjusted performance of 0.1426, and Market Risk Adjusted Performance of (2.38) to validate if our risk estimates are consistent with your expectations.
At this time, HLS Therapeutics' Common Stock Total Equity is very stable compared to the past year. As of the 22nd of July 2025, Capital Stock is likely to grow to about 278.2 M, while Total Stockholder Equity is likely to drop about 65.1 M. . At this time, HLS Therapeutics' Price To Operating Cash Flows Ratio is very stable compared to the past year. As of the 22nd of July 2025, Price To Free Cash Flows Ratio is likely to grow to 11.26, while Price To Sales Ratio is likely to drop 1.19. HLS Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 4.1692 | 50 Day MA 4.866 | Beta 1.1 |
HLS |
Sharpe Ratio = 0.1627
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | HLS | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.78 actual daily | 15 85% of assets are more volatile |
Expected Return
| 0.29 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average HLS Therapeutics is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of HLS Therapeutics by adding it to a well-diversified portfolio.
Price Book 1.695 | Enterprise Value Ebitda 8.9598 | Price Sales 2.7807 | Shares Float 19.1 M | Wall Street Target Price 6.2584 |
HLS Therapeutics Stock Price History Chart
There are several ways to analyze HLS Stock price data. The simplest method is using a basic HLS candlestick price chart, which shows HLS Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | May 27, 2025 | 5.05 |
| Lowest Price | April 24, 2025 | 4.17 |
HLS Therapeutics July 22, 2025 Stock Price Synopsis
Various analyses of HLS Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell HLS Stock. It can be used to describe the percentage change in the price of HLS Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of HLS Stock.| HLS Therapeutics Price Daily Balance Of Power | 0.64 | |
| HLS Therapeutics Accumulation Distribution | 383.60 | |
| HLS Therapeutics Price Rate Of Daily Change | 1.02 | |
| HLS Therapeutics Price Action Indicator | 0.10 |
HLS Therapeutics July 22, 2025 Stock Price Analysis
HLS Stock Price History Data
The price series of HLS Therapeutics for the period between Wed, Apr 23, 2025 and Tue, Jul 22, 2025 has a statistical range of 0.88 with a coefficient of variation of 5.72. Under current investment horizon, the daily prices are spread out with arithmetic mean of 4.74. The median price for the last 90 days is 4.87. The company completed 1:5 stock split on 26th of October 2006. HLS Therapeutics completed dividends distribution on 2023-04-27.| Open | High | Low | Close | Volume | ||
07/21/2025 | 5.00 | 5.00 | 4.86 | 4.99 | 13,700 | |
07/18/2025 | 4.95 | 4.96 | 4.88 | 4.90 | 5,600 | |
07/17/2025 | 4.89 | 4.95 | 4.87 | 4.91 | 35,800 | |
07/16/2025 | 4.90 | 4.90 | 4.87 | 4.89 | 26,100 | |
07/15/2025 | 4.90 | 4.92 | 4.89 | 4.90 | 4,200 | |
07/14/2025 | 5.00 | 5.00 | 4.89 | 4.89 | 2,801 | |
07/11/2025 | 4.88 | 4.88 | 4.81 | 4.86 | 4,700 | |
07/10/2025 | 5.00 | 5.08 | 4.80 | 4.83 | 19,901 | |
07/09/2025 | 4.90 | 4.90 | 4.85 | 4.87 | 6,901 | |
07/08/2025 | 4.88 | 4.88 | 4.85 | 4.88 | 7,300 | |
07/07/2025 | 4.94 | 4.94 | 4.88 | 4.88 | 13,400 | |
07/04/2025 | 4.94 | 4.94 | 4.94 | 4.94 | 6,301 | |
07/03/2025 | 4.86 | 4.90 | 4.85 | 4.90 | 16,345 | |
07/02/2025 | 4.80 | 4.84 | 4.73 | 4.81 | 6,443 | |
06/30/2025 | 4.80 | 4.85 | 4.80 | 4.80 | 47,701 | |
06/27/2025 | 4.80 | 4.86 | 4.75 | 4.79 | 6,301 | |
06/26/2025 | 4.80 | 4.80 | 4.75 | 4.77 | 10,000 | |
06/25/2025 | 4.94 | 4.94 | 4.75 | 4.75 | 23,401 | |
06/24/2025 | 4.91 | 4.96 | 4.90 | 4.94 | 3,802 | |
06/23/2025 | 5.00 | 5.00 | 4.95 | 4.99 | 8,301 | |
06/20/2025 | 4.98 | 5.01 | 4.90 | 4.96 | 11,471 | |
06/19/2025 | 4.96 | 4.97 | 4.95 | 4.97 | 902.00 | |
06/18/2025 | 4.97 | 4.98 | 4.94 | 4.96 | 5,400 | |
06/17/2025 | 4.99 | 4.99 | 4.97 | 4.97 | 1,301 | |
06/16/2025 | 4.89 | 4.99 | 4.89 | 4.99 | 10,000 | |
06/13/2025 | 4.92 | 4.99 | 4.90 | 4.90 | 3,300 | |
06/12/2025 | 4.90 | 4.95 | 4.90 | 4.95 | 800.00 | |
06/11/2025 | 4.94 | 4.94 | 4.81 | 4.93 | 1,100 | |
06/10/2025 | 4.99 | 4.99 | 4.90 | 4.95 | 7,901 | |
06/09/2025 | 4.99 | 4.99 | 4.88 | 4.98 | 2,708 | |
06/06/2025 | 4.93 | 4.98 | 4.91 | 4.92 | 4,230 | |
06/05/2025 | 5.00 | 5.01 | 4.94 | 4.94 | 9,882 | |
06/04/2025 | 5.01 | 5.08 | 4.90 | 4.90 | 19,400 | |
06/03/2025 | 5.08 | 5.10 | 4.95 | 5.00 | 140,725 | |
06/02/2025 | 5.00 | 5.05 | 4.96 | 5.05 | 6,271 | |
05/30/2025 | 4.95 | 4.97 | 4.81 | 4.96 | 3,416 | |
05/29/2025 | 4.90 | 5.00 | 4.90 | 4.95 | 2,500 | |
05/28/2025 | 5.05 | 5.23 | 4.80 | 4.90 | 11,465 | |
05/27/2025 | 5.06 | 5.06 | 4.99 | 5.05 | 7,526 | |
05/26/2025 | 4.70 | 5.10 | 4.69 | 5.00 | 4,500 | |
05/23/2025 | 4.66 | 4.68 | 4.65 | 4.68 | 2,821 | |
05/22/2025 | 4.71 | 4.71 | 4.59 | 4.65 | 5,600 | |
05/21/2025 | 4.83 | 4.85 | 4.71 | 4.71 | 15,500 | |
05/20/2025 | 4.80 | 4.81 | 4.73 | 4.78 | 7,106 | |
05/16/2025 | 4.89 | 4.92 | 4.80 | 4.80 | 7,910 | |
05/15/2025 | 4.80 | 4.80 | 4.71 | 4.71 | 1,770 | |
05/14/2025 | 4.70 | 4.82 | 4.68 | 4.81 | 4,510 | |
05/13/2025 | 4.75 | 4.75 | 4.68 | 4.68 | 5,910 | |
05/12/2025 | 4.25 | 4.61 | 4.24 | 4.50 | 12,000 | |
05/09/2025 | 4.64 | 4.72 | 4.60 | 4.65 | 3,600 | |
05/08/2025 | 4.52 | 4.60 | 4.52 | 4.60 | 1,150 | |
05/07/2025 | 4.47 | 4.49 | 4.43 | 4.49 | 5,300 | |
05/06/2025 | 4.27 | 4.47 | 4.27 | 4.35 | 16,400 | |
05/05/2025 | 4.25 | 4.41 | 4.25 | 4.27 | 10,400 | |
05/02/2025 | 4.43 | 4.43 | 4.33 | 4.40 | 14,000 | |
05/01/2025 | 4.84 | 4.84 | 4.30 | 4.36 | 11,415 | |
| 04/30/2025 | 4.27 | 4.33 | 4.22 | 4.24 | 11,900 | |
04/29/2025 | 4.39 | 4.41 | 4.25 | 4.27 | 17,150 | |
04/28/2025 | 4.23 | 4.44 | 4.23 | 4.34 | 7,305 | |
| 04/25/2025 | 4.17 | 4.36 | 4.17 | 4.23 | 21,505 | |
04/24/2025 | 4.22 | 4.31 | 4.17 | 4.17 | 27,940 |
About HLS Therapeutics Stock history
HLS Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for HLS is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in HLS Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing HLS Therapeutics stock prices may prove useful in developing a viable investing in HLS Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 31.8 M | 23.5 M | |
| Net Loss | -19.7 M | -20.6 M |
HLS Therapeutics Quarterly Net Working Capital |
|
HLS Therapeutics Stock Technical Analysis
HLS Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
HLS Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for HLS Therapeutics' price direction in advance. Along with the technical and fundamental analysis of HLS Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of HLS to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1426 | |||
| Jensen Alpha | 0.2625 | |||
| Total Risk Alpha | (0.01) | |||
| Sortino Ratio | 0.0711 | |||
| Treynor Ratio | (2.39) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Other Information on Investing in HLS Stock
HLS Therapeutics financial ratios help investors to determine whether HLS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HLS with respect to the benefits of owning HLS Therapeutics security.